4109-1922 Screening compound: 4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide

4109-1922 Screening compound: 4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide
4109-1922 Screening compound: 4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 4109-1922
4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4109-1922

Molecular Formula

C32H29N5O4S (C32 H29 N5 O4 S)

Compound Name

4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide

IUPAC name

4-({4-[4-methyl-3-(morpholine-4-sulfonyl)phenyl]phthalazin-1-yl}amino)-N-phenylbenzamide

SMILES

Cc(ccc(-c(c1ccccc11)nnc1Nc(cc1)ccc1C(Nc1ccccc1)=O)c1)c1S(N1CCOCC1)(=O)=O

InChI

InChI=1S/C32H29N5O4S/c1-22-11-12-24(21-29(22)42(39,40)37-17-19-41-20-18-37)30-27-9-5-6-10-28(27)31(36-35-30)33-26-15-13-23(14-16-26)32(38)34-25-7-3-2-4-8-25/h2-16,21H,17-20H2,1H3,(H,33,36)(H,34,38)

InChI Key

LKTJMZVOJYDPPW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02239415

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

579.68

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.124

Distribution Coefficient, logD

5.124

Water Solubility, LogSw

-5.18

Polar Surface Area

94.472

Acid Dissociation Constant (pKa)

11.01

Base Dissociation Constant (pKb)

4.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.60

4109-1922 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 4109-1922 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4109-1922?
Check Price and Availability of 4109-1922, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4109-1922 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4109-1922
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4109-1922
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4109-1922 available by request